TABLE 1
Demographics and Baseline Characteristics for 19 Subjects Enrolled in Study
| Subject no. | Study | MMSE | Age (y) |  | Amyloid positive (+) or negative (−) |
| AD-1 | A | 29 | 70 | 1.970 | + |
| AD-2 | B | 18 | 65 | 1.750 | + |
| AD-3 | A | 23 | 77 | 1.420 | + |
| AD-4 | A | 18 | 58 | 1.570 | + |
| AD-5 | B | 21 | 89 | 1.300 | + |
| MCI-1 | A | 17 | 77 | 1.790 | + |
| MCI-2 | A | 29 | 77 | 1.510 | + |
| MCI-3 | A | 26 | 82 | 1.630 | + |
| MCI-4 | B | 29 | 76 | 1.600 | + |
| MCI-5 | B | 26 | 70 | 1.580 | + |
| OCN-1 | B | 29 | 60 | 1.220 | + |
| OCN-2 | A | 30 | 66 | 1.130 | + |
| OCN-3 | A | 30 | 66 | 1.000 | − |
| OCN-4 | A | 30 | 67 | 0.800 | − |
| OCN-5 | A | 29 | 66 | 1.050 | − |
| YCN-1 | A | 30 | 28 | NA | NA |
| YCN-2 | A | 30 | 27 | NA | NA |
| YCN-3 | A | 30 | 25 | NA | NA |
| YCN-4 | A | 29 | 30 | NA | NA |
NA = not applicable; SUVRFB = florbetapir SUVR.